decisionhealth Newsletters, Coder Pink Sheets - 2009 Issue 6 (June)
Medicare pays separately for Triesence
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare payment correction issued by CMS for an ophthalmic drug product used in ambulatory surgery centers. It explains the policy update, the affected setting, the timing of the retroactive correction, and the general payment and billing context that readers in ophthalmology, ASC management, and medical coding should understand. The piece also points to official CMS transmittals and notes the broader clinical use context for the product discussed.
Why This Topic Matters
The article matters because it corrects a Medicare ASC payment interpretation and affects whether the drug is paid separately. That directly impacts claim preparation, payment recovery, and awareness of retroactive resubmission opportunities for affected facilities.
What You Will Learn
- How CMS corrected its ASC payment treatment for an ophthalmic HCPCS drug code
- Why the ambulatory surgery center setting is relevant to the payment issue
- What general timing and retroactive payment context CMS associated with the correction
- Where the article directs readers to find the related CMS transmittals
Who Should Read This
- ASC administrators
- Medical coders
- Billing staff
- Ophthalmology practices
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com